Association of CTLA-4 (+49A/G) Gene Polymorphism with Type 1 Diabetes Mellitus in Egyptian Children

被引:30
作者
Mosaad, Youssef M. [1 ]
Elsharkawy, Ashraf A. [2 ]
El-Deek, Basem S. [3 ]
机构
[1] Mansoura Univ, Mansoura Fac Med, Dept Clin Pathol, Clin Immunol Unit, Mansoura 35111, Egypt
[2] Mansoura Univ, Childrens Hosp, Mansoura Fac Med, Pediat Endocrinol & Diabet Unit, Mansoura 35111, Egypt
[3] Mansoura Fac Med, Community Med & Stat Dept, Mansoura 35111, Egypt
关键词
CTLA-4; T1D; RFLP; Children; Egyptian; GRAVES-DISEASE; CONFERS SUSCEPTIBILITY; A/G POLYMORPHISM; ONSET; PROMOTER; REGION; IDDM; AUTOIMMUNITY; POSITION-49; GENOTYPE;
D O I
10.3109/08820139.2011.579215
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To investigate the distribution of cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) (+49 A/G) gene variants and the association of these variants with the clinical and laboratory findings in Egyptian children with Type-1 Diabetes (T1D). Methods: A case control study was done for 104 Egyptian children with T1D and 78 age and sex matched healthy control. CTLA-4 (+49 A/G) gene polymorphism typing was done by PCR amplification followed by restriction fragment length polymorphism (RFLP) method. Results: CTLA-4 G allele and GG homozygous genotype were significantly increased in T1D patients than in control group (P = 0.047, P = 0.048 respectively). There is no statistical difference between patient with optimal diabetic control (HbA1c < 8.5) and poor control (HbA1c >= 8.5) as regarding the CTLA-4 gene variant. The CTLA-4 GG genotype was statistically associated with younger age of patients (P = 0.027) and younger age of presentation (P = 0.036). Insignificant association was found between CTLA-4 alleles / genotypes and diabetic complications. Conclusion: The CTLA-4 + 49 GG homozygous genotype is associated with T1D in Egyptian children especially with younger age of onset and in younger patients, and not associated with grades of diabetic control or diabetic complication.
引用
收藏
页码:28 / 37
页数:10
相关论文
共 41 条
[1]   CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese Type 1 diabetes [J].
Abe, T ;
Takino, H ;
Yamasaki, H ;
Ozaki, M ;
Sera, Y ;
Kondo, H ;
Sakamaki, H ;
Kawasaki, E ;
Awata, T ;
Yamaguchi, Y ;
Eguchi, K .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 46 (02) :169-175
[2]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[3]   Associations of the CTLA-4 polymorphisms with type 1 diabetes in a Chilean population: Case-parent design [J].
Angel, Barbara ;
Balic, Ivan ;
Luis Santos, Jose ;
Codner, Ethel ;
Carrasco, Elena ;
Perez-Bravo, Francisco .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 85 (03) :E34-E36
[4]   A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele [J].
Anjos, S ;
Nguyen, A ;
Ounissi-Benkalha, H ;
Tessier, MC ;
Polychronakos, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (48) :46478-46486
[5]   Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves disease and Hashimoto's thyroiditis) in the Japanese population [J].
Awata, T ;
Kurihara, S ;
Iitaka, M ;
Takei, S ;
Inoue, I ;
Ishii, C ;
Negishi, K ;
Izumida, T ;
Yoshida, Y ;
Hagura, R ;
Kuzuya, N ;
Kanazawa, Y ;
Katayama, S .
DIABETES, 1998, 47 (01) :128-129
[6]   Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children [J].
Balic, Ivan ;
Angel, Barbara ;
Codner, Ethel ;
Carrasco, Elena ;
Perez-Bravo, Francisco .
HUMAN IMMUNOLOGY, 2009, 70 (02) :116-120
[7]   Role of PTPN22 in type 1 diabetes and other autoimmune diseases [J].
Bottini, Nunzio ;
Vang, Torkel ;
Cucca, Francesco ;
Mustelin, Tomas .
SEMINARS IN IMMUNOLOGY, 2006, 18 (04) :207-213
[8]   CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus [J].
Donner, H ;
Rau, H ;
Walfish, PG ;
Braun, J ;
Siegmund, T ;
Finke, R ;
Herwig, J ;
Usadel, KH ;
Badenhoop, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :143-146
[9]   A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine [J].
Doyle, EA ;
Weinzimer, SA ;
Steffen, AT ;
Ahern, JAH ;
Vincent, M ;
Tamborlane, WV .
DIABETES CARE, 2004, 27 (07) :1554-1558
[10]   Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways [J].
Fife, Brian T. ;
Bluestone, Jeffrey A. .
IMMUNOLOGICAL REVIEWS, 2008, 224 :166-182